Wendy A. Thomas

2.3k total citations
18 papers, 1.9k citations indexed

About

Wendy A. Thomas is a scholar working on Oncology, Immunology and Epidemiology. According to data from OpenAlex, Wendy A. Thomas has authored 18 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 9 papers in Immunology and 8 papers in Epidemiology. Recurrent topics in Wendy A. Thomas's work include Viral-associated cancers and disorders (16 papers), Cytomegalovirus and herpesvirus research (7 papers) and Lymphoma Diagnosis and Treatment (6 papers). Wendy A. Thomas is often cited by papers focused on Viral-associated cancers and disorders (16 papers), Cytomegalovirus and herpesvirus research (7 papers) and Lymphoma Diagnosis and Treatment (6 papers). Wendy A. Thomas collaborates with scholars based in United Kingdom, Germany and Australia. Wendy A. Thomas's co-authors include Alan B. Rickinson, Martin Rowe, Jill Brooks, Michael G. Kurilla, R J Murray, E Kieff, Steven P. Lee, Neil Blake, Rosemary J. Tierney and J Crocker and has published in prestigious journals such as The Journal of Experimental Medicine, Blood and The Journal of Immunology.

In The Last Decade

Wendy A. Thomas

17 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wendy A. Thomas United Kingdom 17 1.5k 1.1k 677 645 199 18 1.9k
Barbro Ehlin‐Henriksson Sweden 25 1.1k 0.7× 839 0.8× 569 0.8× 418 0.6× 221 1.1× 43 1.8k
Heather M. Long United Kingdom 24 1.2k 0.8× 902 0.9× 553 0.8× 596 0.9× 173 0.9× 37 1.8k
Rosemary J. Tierney United Kingdom 20 1.2k 0.8× 465 0.4× 647 1.0× 441 0.7× 155 0.8× 26 1.5k
T B Sculley Australia 26 1.8k 1.2× 937 0.9× 878 1.3× 776 1.2× 185 0.9× 53 2.3k
Ken‐Ichi Imadome Japan 22 859 0.6× 606 0.6× 409 0.6× 330 0.5× 188 0.9× 103 1.4k
F Wang United States 12 1.7k 1.1× 461 0.4× 894 1.3× 472 0.7× 160 0.8× 12 1.8k
Andreas Moosmann Germany 24 1.3k 0.9× 1.0k 0.9× 302 0.4× 830 1.3× 378 1.9× 54 2.1k
R J Murray United Kingdom 12 1.1k 0.7× 776 0.7× 522 0.8× 508 0.8× 115 0.6× 14 1.5k
D Liebowitz United States 13 1.5k 1.0× 414 0.4× 881 1.3× 328 0.5× 133 0.7× 14 1.7k
Daphne van Leeuwen Netherlands 18 849 0.6× 797 0.8× 190 0.3× 691 1.1× 233 1.2× 20 1.5k

Countries citing papers authored by Wendy A. Thomas

Since Specialization
Citations

This map shows the geographic impact of Wendy A. Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wendy A. Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wendy A. Thomas more than expected).

Fields of papers citing papers by Wendy A. Thomas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wendy A. Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wendy A. Thomas. The network helps show where Wendy A. Thomas may publish in the future.

Co-authorship network of co-authors of Wendy A. Thomas

This figure shows the co-authorship network connecting the top 25 collaborators of Wendy A. Thomas. A scholar is included among the top collaborators of Wendy A. Thomas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wendy A. Thomas. Wendy A. Thomas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Zuo, Jianmin, Wendy A. Thomas, Tracey A. Haigh, et al.. (2011). Epstein-Barr Virus Evades CD4+ T Cell Responses in Lytic Cycle through BZLF1-mediated Downregulation of CD74 and the Cooperation of vBcl-2. PLoS Pathogens. 7(12). e1002455–e1002455. 52 indexed citations
2.
3.
Fitzsimmons, Leah, et al.. (2010). Quantitative Studies of Epstein-Barr Virus-Encoded MicroRNAs Provide Novel Insights into Their Regulation. Journal of Virology. 85(2). 996–1010. 89 indexed citations
4.
Brooks, Jill, Steven P. Lee, Alison M. Leese, et al.. (2009). Cyclical Expression of EBV Latent Membrane Protein 1 in EBV-Transformed B Cells Underpins Heterogeneity of Epitope Presentation and CD8+ T Cell Recognition. The Journal of Immunology. 182(4). 1919–1928. 26 indexed citations
5.
Zuo, Jianmin, Bryan D. Griffin, Claire Shannon‐Lowe, et al.. (2009). The Epstein-Barr Virus G-Protein-Coupled Receptor Contributes to Immune Evasion by Targeting MHC Class I Molecules for Degradation. PLoS Pathogens. 5(1). e1000255–e1000255. 143 indexed citations
6.
Kelly, Gemma L., Heather M. Long, Julianna Stylianou, et al.. (2009). An Epstein-Barr Virus Anti-Apoptotic Protein Constitutively Expressed in Transformed Cells and Implicated in Burkitt Lymphomagenesis: The Wp/BHRF1 Link. PLoS Pathogens. 5(3). e1000341–e1000341. 136 indexed citations
7.
Lee, Steven P., Jill Brooks, Wendy A. Thomas, et al.. (2004). CD8 T Cell Recognition of Endogenously Expressed Epstein-Barr Virus Nuclear Antigen 1. The Journal of Experimental Medicine. 199(10). 1409–1420. 125 indexed citations
8.
Rickinson, A. B., et al.. (2001). Epstein-Barr virus-specific cytotoxic T lymphocyte responses in the blood and tumor site of Hodgkin's disease patients: implications for a T-cell-based therapy.. PubMed. 61(16). 6219–26. 75 indexed citations
9.
Lee, Steven P., Anthony T.�C. Chan, ST Cheung, et al.. (2000). CTL Control of EBV in Nasopharyngeal Carcinoma (NPC): EBV-Specific CTL Responses in the Blood and Tumors of NPC Patients and the Antigen-Processing Function of the Tumor Cells. The Journal of Immunology. 165(1). 573–582. 96 indexed citations
10.
Thomas, Wendy A.. (1999). Developing a national Web site: the Canadian experience. Museum International. 51(4). 14–19.
11.
12.
13.
Tierney, Rosemary J., et al.. (1997). Conserved CTL epitopes within EBV latent membrane protein 2: a potential target for CTL-based tumor therapy. The Journal of Immunology. 158(7). 3325–3334. 178 indexed citations
14.
Lee, Steven P., Wendy A. Thomas, Neil Blake, & Alan B. Rickinson. (1996). Transporter (TAP)‐independent processing of a multiple membrane‐spanning protein, the Epstein‐Barr virus latent membrane protein 2. European Journal of Immunology. 26(8). 1875–1883. 51 indexed citations
15.
16.
Brooks, Jill, R J Murray, Wendy A. Thomas, Michael G. Kurilla, & Alan B. Rickinson. (1993). Different HLA-B27 subtypes present the same immunodominant Epstein-Barr virus peptide.. The Journal of Experimental Medicine. 178(3). 879–887. 89 indexed citations
17.
Thomas, Wendy A., R J Murray, Farhat L. Khanim, et al.. (1993). HLA A2.1-restricted cytotoxic T cells recognizing a range of Epstein-Barr virus isolates through a defined epitope in latent membrane protein LMP2. Journal of Virology. 67(12). 7428–7435. 161 indexed citations
18.
Murray, R J, Michael G. Kurilla, Jill Brooks, et al.. (1992). Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies.. The Journal of Experimental Medicine. 176(1). 157–168. 428 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Barbro Ehlin‐Henriksson Breakdown of academic impact, for papers by Heather M. Long Breakdown of academic impact, for papers by Rosemary J. Tierney Breakdown of academic impact, for papers by T B Sculley Breakdown of academic impact, for papers by Ken‐Ichi Imadome Breakdown of academic impact, for papers by F Wang Breakdown of academic impact, for papers by Andreas Moosmann Breakdown of academic impact, for papers by R J Murray Breakdown of academic impact, for papers by D Liebowitz Breakdown of academic impact, for papers by Daphne van Leeuwen
Rankless by CCL
2026